Ozempic label now notes potential side effect of intestinal blockage
The U.S. Food and Drug Administration (FDA) updated the label for Ozempic, a type 2 diabetes drug that is often used for weight loss, to now note the potential side effect of intestinal blockage.
37 other sources covering this story
Total News Sources
5 months ago